Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 7;2(2):e229-e232.
doi: 10.1055/s-0038-1660506. eCollection 2018 Apr.

Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation

Romain Chopard  1 , Samuel Z Goldhaber  1 , Neelima Karipineni  2 , Howard S Goldberg  2 , Gregory Piazza  1
Affiliations

Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation

Romain Chopard et al. TH Open. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest Dr. Chopard has received research grant support from the French Federation of Cardiology, the Burgundy Franche-Comte region, and Edwards Lifesciences.

Dr. Goldhaber has received research grant support from Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, the Thrombosis Research Institute, and Janssen and consulting fees from Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Eisai, and Portola.

Dr. Piazza has received research grant support from Bristol Myers Squibb, Daiichi Sankyo, the Thrombosis Research Institute, and Janssen.

Drs. Karipineni and Goldberg have no relevant financial disclosures.

Figures

Fig. 1
Fig. 1
Multivariate analysis of factors associated with anticoagulant nonprescription versus prescription in patients with atrial fibrillation at risk of stroke (CHA 2 DS 2 -VASc score ≥2). AC, anticoagulant; AF, atrial fibrillation; CI, confidence interval; RR, relative risk.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Hart R G, Pearce L A, Aguilar M I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857–867. - PubMed
    1. Ruff C T, Giugliano R P, Braunwald Eet al.Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet 2014383(9921):955–962. - PubMed
    1. Wann L S, Curtis A B, Ellenbogen K A et al.2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2011;57(11):1330–1337. - PubMed
    1. Connolly S J, Eikelboom J, Joyner C et al.Apixaban in patients with atrial fibrillation. N Engl J Med. 2011;364(09):806–817. - PubMed
    1. Mant J, Hobbs F D, Fletcher Ket al.Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 2007370(9586):493–503. - PubMed